By HLTH
4.9
1010 ratings
The podcast currently has 222 episodes available.
Today, Host Sandy Vance is talking with Robert Dwyer, PhD EVP, Chief Data Scientist at Certilytics about AI and healthcare. Dr. Dwyer is here to help demystify and readiness of generative AI. They delve into the transformative impact of generative AI on healthcare data and its revolutionary potential for the industry. Join us as we explore Certilytics, a company dedicated to creating a user-friendly interface for interacting with healthcare data, and their role in empowering healthcare organizations to enhance their efficiency with AI.
AI's role in healthcare is now presenting new opportunities for healthcare data and analytics to go beyond just Large Language Models (LLMs) and deliver business intelligence that can impact healthcare administration strategies and help accelerate improved outcomes & efficiency in healthcare.
In this episode, they talk about:
A Little About Dr. Robert Dwyer:
Dr. Dwyer joined Certilytics in 2014, bringing over a decade of mathematical modeling and machine learning experience in both the private sector and academia, where he worked on problems ranging from the quantification of medical and financial risk to predictive genomics. He is responsible for overseeing the design and pathing of new ML/AI products. Dr. Dwyer graduated from the University of Virginia in 2009 with a B.S. in Biology. He then obtained his M.S. and Ph.D. in computational biology from Princeton University, where he developed variations of maximum entropy algorithms to predict three-dimensional protein folding patterns by mining genomic sequence data. Prior to Certilytics, he worked with a number of startups and think tanks to develop algorithms to predict student loan repayment rates and to track Defense Department allocations.
Do you have any questions for Robert Dwyer? Reach out by emailing him at [email protected].
About Ezra Melhman:
Ezra Melhman is a seasoned healthcare investor and business leader with a rich background in providing strategic guidance to hospitals, healthcare systems, and healthcare companies. He joined Health Enterprise Partners (HEP) in 2010, as a Managing Partner, bringing with him a wealth of experience in consulting and research services for the healthcare industry.
Before joining HEP, Ezra served as a Senior Analyst at the Advisory Board Company (NASDAQ: ABCO), where he offered best-practice consulting and research services to hospitals and health systems. Following his tenure at the Advisory Board Company, he further honed his expertise as a Senior Consultant at Booz Allen Hamilton, focusing on engagements in the provider space.
Currently, Ezra holds positions on the board of directors of several prominent healthcare companies, including The Intermed Group, Wildflower Health, Kno2, Proven Behavior Solutions, Family First Adolescent Services, and Aware Recovery Care. He has a proven track record of successful board engagements, having previously served on the boards of AxiaMed, Applied Pathways, CenterPointe Behavioral Health System, InDemand Interpreting, Jvion, and Twistle, all of which were acquired by leading healthcare entities.
In addition to his board roles, Ezra contributes to academia as a member of the faculty at Columbia Business School and serves on the Health Policy and Management Executive Council at Harvard School of Public Health. He holds a BA cum laude from Washington University in St. Louis and earned his MBA from Columbia Business School. With his extensive experience and dedication to advancing healthcare, Ezra continues to make significant contributions to the industry.
Things You’ll Learn:
Resources:
About Lynne Chou O'Keefe:
Lynne Chou O’Keefe is the Founder and Managing Partner of Define Ventures, an early stage venture capital firm focused on investing in digital health companies redefining healthcare. Define Ventures focuses on incubation, seed, Series A, and Series B-stage digital health startups (www.definevc.com). Lynne has partnered with entrepreneurs to help them build category-defining digital health companies, such as Livongo (NASDAQ: LVGO), HIMS (NASDAQ: HIMS), Unite Us, etc. Previous to Define Ventures, Lynne’s experience includes both healthcare operating, investing, and finance roles. Previously, she was a Senior Partner at Kleiner Perkins, focused on digital health and connected devices early-stage investing. Before joining Kleiner Perkins, Lynne worked at Abbott Vascular and Guidant in multiple roles, launching over ten product families in the US and internationally. Lynne was responsible for building the global commercial strategy and therapy development, as well as playing a key role in the clinical, reimbursement, and operational strategy for these therapies. Earlier in her career, Lynne worked at Apax Partners with a focus on software venture capital investing. In addition, Lynne worked at Goldman Sachs in the Mergers and Acquisitions group and worked on multiple multi-billion dollar acquisitions and sell-side transactions in various industries. Lynne has been named WSJ’s Women in Venture Capital to Watch in 2020. Lynne earned a Bachelor of Science degree in Industrial Engineering from Stanford University and an M.B.A. from Harvard Business School.
Things You’ll Learn:
Resources:
About Scott Barclay:
Scott Barclay is a Managing Director at Insight Partners based in Palo Alto. His Computational Care thesis envisions the future of US and global healthcare built at the intersection of empathy and scalable technology. Scott’s early career traversed capital markets with Banc of America Securities in Europe and the US, The Boston Consulting Group, and CVS Health. At CVS and then after, Scott helped create and scale the nation’s e-prescribing ecosystem, running iScribe (acq Allscripts) and as Chief Strategy Officer of Surescripts. Prior to Insight, Scott built his investing career as a healthcare angel investor and advisor (NaviHealth, Doximity, Elation) and, from 2015 – 2020, as a Partner at DCVC, a world-class early-stage deep tech venture capital firm, where he was a director or observer on the Boards of companies like Carbon Health, Freenome, SafelyYou, and many others.
Things You’ll Learn:
Resources:
About Ian Wijaya:
Ian Wijaya is the Co-Head of Lazard’s North America Healthcare practice. Ian joined Lazard in 2011 and co-founded the Firm’s healthcare services practice, with a focus on M&A, strategic advisory, and recapitalization advisory for managed care insurance payers, providers across the continuum of care (e.g., acute care hospitals, ambulatory surgery centers, post-acute care, etc.), PBMs, distributors, payor and provider services companies, HCIT, and digital health companies.
Ian is a member of Lazard’s Opinion Committee and the World Economic Forum’s Global Future Council on Healthcare, as well as a Corporate Leader on the Council on Foreign Relations.
Ian has advised on more than $250 billion of corporate finance transactions, including mergers and acquisitions, leveraged buyouts, financial restructurings and reorganizations, joint ventures, and other matters, and has advised on several of the largest and most transformative M&A transactions in healthcare, including three of the largest in recent history.
Prior to joining Lazard, Ian was an investment banker at Greenhill & Co. in New York, where he focused on healthcare M&A but also provided M&A advice to companies in the technology and retail sectors. Prior to Greenhill & Co., he worked in the Investment Banking Division of Goldman Sachs & Co. and the financial restructuring group of Houlihan Lokey in New York.
Ian has an M.B.A. in Finance and Strategy from Northwestern University’s Kellogg School of Management and a B.A. (cum laude) from Dartmouth College.
Things You’ll Learn:
Resources:
About Omkar Kulkarni:
Omkar P. Kulkarni is the first chief innovation officer at Children’s Hospital Los Angeles. In his role, Kulkarni is responsible for fostering innovation across Children’s Hospital Los Angeles's clinical and research enterprises – including launching an enterprise virtual care program, incubating and implementing new digital health tools and medical devices, and rallying communities inside and outside of the hospital to solve problems in the field of pediatrics – all with the goal of enhancing the experience and outcomes for the children and families Children’s Hospital Los Angeles serves. Kulkarni is also the founder and managing director of KidsX, a consortium-based digital health accelerator that is comprised of over fifteen leading pediatric hospitals from around the world.
Prior to joining Children’s Hospital Los Angeles, Kulkarni served as executive director of the Cedars-Sinai Accelerator powered by Techstars, where he helped build and launch the accelerator program. In that role, he evaluated over 3,000 healthcare start-ups and provided extensive mentoring, serving as the main liaison between the start-up community and Cedars-Sinai Medical Center. Kulkarni also led the performance improvement department at Cedars-Sinai for many years and has experience in financial process redesign at NewYork-Presbyterian Hospital. Kulkarni has a master’s degree in public health and health care management from Columbia University and a bachelor’s degree in business administration from George Washington University.
Things You’ll Learn:
Resources:
About Dr. Eve Cunningham:
Eve Cunningham, MD MBA, the Chief of Virtual Care and Digital Health at Providence, and an active member of the HIMSS community. Throughout her career, she's balanced surgical skills as a gynecologist with incubating and scaling digital assistant products for providers at Providence.
Balancing career with spouse and three children has been her biggest challenge. She advises working mothers to customize their balance based on beliefs, resources, and support. As a leader, she's sensitive to her team's challenges, balancing work and life.
Her future challenge is navigating healthcare transformation and integrating AI/ML technology into clinical workflows, advocating for clinician involvement to ensure responsible use.
Cunningham believes the future of health information and technology for women is bright, with more entering the field and changing gender ratios emphasizing value and competency.
Motivated by mentorship, she resonates with Steve Jobs' quotes on teamwork and revolutionary change. Cunningham is proud to serve on HIMSS committees and recently participated in the CMIO Panel at HIMSS22, focusing on innovations to address burnout and administrative burden.
Things You’ll Learn:
Resources:
About Ken Washington:
Ken Washington serves as the Senior Vice President and Chief Technology and Innovation Officer at Medtronic, leading the charge in accelerating innovation through strategic product development and technology initiatives. With a wealth of experience spanning various industries including robotics, consumer products, automotive, and space, Ken joined Medtronic in 2023, bringing deep expertise in technology development and execution.
As a visionary leader, Ken inspires and motivates teams to push the boundaries of invention and innovation, driving positive market disruptions. He collaborates closely with teams and leaders across Medtronic to ensure the continuous advancement of products and therapies in alignment with the company's mission to better serve patients and customers.
Prior to his role at Medtronic, Ken held notable positions including Vice President and General Manager of Consumer Robotics at Amazon and Chief Technology Officer at Ford Motor Company, where he oversaw the development of technology strategies and next-generation vehicle architectures. With seven years at Lockheed Martin, Ken held various leadership roles, including Chief Technology Officer and Vice President of the Advanced Technology Center.
Ken is internationally recognized as a thought leader in technology and innovation, with accolades including induction into the National Academy of Engineering in 2020 and the Black Engineer Hall of Fame in 2023. He holds a Bachelor of Science, a Master of Science, and a PhD in nuclear engineering from Texas A&M University.
Things You’ll Learn:
Resources:
About Max Cohen:
Max Cohen serves as the CEO and Co-founder of Sprinter Health, headquartered in California. The company deploys W-2 employees, dubbed "Sprinters," equipped with the medical assistant, phlebotomy, and Community Health Worker expertise, directly into households to engage patient populations that may otherwise be disengaged. Sprinter collaborates with health plans and health systems, offering preventive services with no copay or deductible. Prior to launching Sprinter Health, Max held the position of VP of Mobile at Oculus, and following the acquisition by Facebook continued to oversee various initiatives including Mobile VR, Mobile and Platform Products, and Media. Before his tenure at Oculus, Max contributed to the Product team at Google in Los Angeles and gained experience at McKinsey and Company, as well as Lockheed Martin's Skunk Works. Max holds a BSE in Electrical Engineering and a BS in Physics from Duke University, supplemented by an MBA from Harvard Business School.
Things You’ll Learn:
Resources:
About Yuechen Zhao :
Yuechen is a Partner at GSR Ventures, where he focuses on early-stage investments in enterprise software and consumer platforms. Prior to GSR Ventures, Yuechen founded a personalized travel startup and built products at Google, Uber, and Meixin (fintech). Yuechen received his BA in Computer Science from Harvard University.
Things You’ll Learn:
Resources:
The podcast currently has 222 episodes available.
4,186 Listeners
1,170 Listeners
958 Listeners
221 Listeners
28,933 Listeners
19 Listeners
634 Listeners
55,937 Listeners
25,851 Listeners
7,176 Listeners